Tim Martin, MD, highlights that the downsides of Semaglutide often revolve around gastrointestinal adaptation
While this has not been conclusively shown in humans, it is a potential concern
PubMed laboratory research record [PMID: 15071358] PubMed record related to this compound for laboratory literature review
However, unlike other GLP-1 RA drugs that require injection, Rybelsus is notable for being the first in its class to be available in an oral tablet form, making it a convenient option for diabetes patients looking to manage their condition with less invasive treatment methods
Dry mouth, changes in taste, constipation, stomach ache, fatigue, headache, dry skin, and dizziness are all common symptoms that can indicate a slipping fluid balance
Trivia The global skin-lightening industry was worth USD 9.7 billion in 2023 and is expected to reach USD 16 billion by 2033